View Future GrowthNippon Shokubai 과거 순이익 실적과거 기준 점검 2/6Nippon Shokubai은 연평균 16.1%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 4% 감소했습니다. 매출은 연평균 4.6%의 비율로 증가했습니다. Nippon Shokubai의 자기자본이익률은 4.3%이고 순이익률은 4.2%입니다.핵심 정보16.13%순이익 성장률17.27%주당순이익(EPS) 성장률Chemicals 산업 성장률12.93%매출 성장률4.55%자기자본이익률4.30%순이익률4.19%다음 순이익 업데이트07 Aug 2026최근 과거 실적 업데이트공시 • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026공시 • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026공시 • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026공시 • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025공시 • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025공시 • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025모든 업데이트 보기Recent updates공시 • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.공시 • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026공시 • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026공시 • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026공시 • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025공시 • Jul 31Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 5,000,000 shares, representing 3.3% for ¥7,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 5,000,000 shares, representing 3.3% of its issued share capital (excluding treasury stock), for a total purchase price of ¥7,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 27, 2026. As of June 30, 2025, the company has 151,691,868 issued shares (excluding treasury stock) and 4,308,132 treasury shares.공시 • Jun 26Nippon Shokubai's U.S. Group Company Acquires Iscc Plus Certification for Acrylic Acid and Superabsorbent PolymersNippon Shokubai Group companies in the United States have acquired ISCC PLUS certification for acrylic acid (hereinafter "AA") and superabsorbent polymers (hereinafter "SAP") produced locally. This enables Nippon Shokubai group to globally supply AA and SAP with a carbon footprint considered net zero. Through promoting the use of ISCC PLUS-certified AA and SAP, NipponShokubai Group aims to contribute to reducing environmental impact across the supply chain and to advancing a circular economy. Toward carbon neutrality by 2050, Nippon ShokubAI Group will continue to implement the "transformation" outlined in its long-term vision and mid-term management plan to enhance customer value. Nippon Shokubia Group commits and declares its compliance with the ISCC PLUS requirements in accordance with the latest ISCC regulations. ISCC (International Sustainability and Carbon Certification): It is a third-party certification program developed by International Sustainability and Carbon Certification (ISCC) system GmbH based in Germany to manage and guarantee sustainable raw materials and products such as biomass and recycled materials in the supply chain. Carbon footprint considered net zero: ISCC PLUS-certified products incorporate the biogenic CO2 removal associated with biomass growth into their carbon footprint calculations. The carbon footprints of these products are considered effectively net zero through the proportionally offset based on the share of biomass-derived feedstock allocated using the mass balance method. The mass balance method: When biomass-derived and petroleum-derived raw materials are used together in production, the proportion of biomass input can be allocated to specific end products. This method is officially recognized under the ISCC PLUS certification system.공시 • Jun 24Nippon Shokubai Plans to Expand Its Gmp-Compliant Nucleic Acid Drug API Manufacturing Capacity TenfoldNippon Shokubai CO., LTD. has announced a plan to expand its GMP (1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) tenfold in response to rapidly growing global demand in the nucleic acid drug market. Nucleic acid drugs are generally defined as "chemically synthesized drugs with oligonucleotides as active ingredients that exert their effects without being translated into proteins." As a new modality following small molecule and antibody drugs, they are expected to be applied in areas such as rare diseases, neurological disorders, and cancers -- fields where conventional treatments have been limited. The capacity expansion will involve the installation of a large-scale production line with ten times the capacity (several kilograms per batch) of the company's existing line. The new facility is scheduled to begin operation in 2027, making it one of Japan's largest CDMOs, capable of manufacturing nucleic acid drug APIs for common diseases that require large-scale supply. The company will strengthen its manufacturing system to meet a wide range of needs, from non-clinical stages to large-scale commercial production. Leveraging Nippon Shokubai's long-standing expertise in organic synthesis and rigorous quality control systems, the company manufactures oligonucleotides and peptides, which are medium-sized molecule APIs. Its GMP-compliant facilities, among the most advanced in Japan, have been audited and visited by multiple pharmaceutical companies, all of which have given high evaluations, establishing Nippon ShokubAI's strong reputation in the industry. The company will continue to provide flexible contract manufacturing services that meet diverse needs and contribute to a sustainable society by ensuring a stable supply of medium-sized molecule APIs that support human health and life.공시 • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025공시 • May 13+ 3 more updatesNippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025.공시 • Apr 02Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation.Nippon Shokubai Co., Ltd. (TSE:4114) agreed to acquire Emulsion Technology Co.,Ltd. from JSR Corporation for ¥7.2 billion on November 12, 2024. As part of consideration, ¥7.2 billion is paid towards common equity of Emulsion Technology Co.,Ltd. For the period ending March 31, 2024, Emulsion Technology Co.,Ltd. reported total revenue of ¥13.3 billion, EBIT of ¥918 million and net income of ¥647 million. The expected completion of the transaction is April 1, 2025. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation on April 1, 2025.공시 • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025공시 • Dec 12Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd.Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd. on December 9, 2024. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Lilac Pharma Co., Ltd. on December 9, 2024.공시 • Nov 11Nippon Shokubai Co., Ltd. to Report Q3, 2025 Results on Feb 06, 2025Nippon Shokubai Co., Ltd. announced that they will report Q3, 2025 results at 3:00 PM, Tokyo Standard Time on Feb 06, 2025공시 • Aug 15Nippon Shokubai Co., Ltd. to Report Q2, 2025 Results on Nov 07, 2024Nippon Shokubai Co., Ltd. announced that they will report Q2, 2025 results on Nov 07, 2024공시 • May 15Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024.공시 • May 14Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 4,000,000 shares, representing 2.59% for ¥5,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.59% of its issued share capital (excluding treasury stock), for a total purchase price of ¥5,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 28, 2025. As of March 31, 2024, the company has 154,642,750 issued shares (excluding treasury stock) and 1,357,240 treasury shares.공시 • Mar 02Nippon Shokubai Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024공시 • Feb 09+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. announced that For the fiscal year ending March 31, 2023, the company to forecasts to pay a dividend of JPY 90.00 per share as compared to JPY 90.00 per share paid a year ago.매출 및 비용 세부 내역Nippon Shokubai가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:NSHK.F 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 26399,89816,76457,635031 Dec 25400,05817,74056,455030 Sep 25402,66716,08140,97914,36230 Jun 25405,49817,19754,154031 Mar 25409,34617,39438,93114,36231 Dec 24408,26715,22853,581030 Sep 24404,58413,07239,05413,72030 Jun 24399,74211,06452,238031 Mar 24392,00911,00837,52313,72031 Dec 23386,3938,75936,75414,36630 Sep 23394,20112,18437,85314,36630 Jun 23405,42516,37640,39414,36631 Mar 23419,56819,39242,47814,36631 Dec 22425,01724,82343,12713,77630 Sep 22415,97325,43942,01813,77630 Jun 22394,74125,66838,15513,77631 Mar 22369,29323,72035,21613,77631 Dec 21347,5156,89733,22713,21730 Sep 21321,4832,63431,19813,21730 Jun 21296,284-6,82029,51613,21731 Mar 21273,163-10,89928,26913,21731 Dec 20270,5063,28427,17113,39930 Sep 20273,5264,18027,09613,39930 Jun 20288,0969,39327,88113,39931 Mar 20302,15011,09428,50413,39931 Dec 19298,16313,14730,67612,58330 Sep 19314,76616,65230,06312,58330 Jun 19326,68119,53829,24212,58331 Mar 19338,86923,84928,34012,58331 Dec 18347,43525,69826,98812,05130 Sep 18341,15925,19527,19512,05130 Jun 18331,68525,46527,52112,05131 Mar 18322,80124,28027,35812,05131 Dec 17327,82522,94728,11712,13630 Sep 17314,70622,87027,65912,13630 Jun 17302,27021,00427,16112,13631 Mar 17293,97019,36127,18312,13631 Dec 16284,71520,16635,8922,95930 Sep 16294,37320,02833,0125,69730 Jun 16310,20122,42130,3318,48831 Mar 16323,12426,00327,49711,27031 Dec 15347,36626,14227,84911,33530 Sep 15362,63526,08928,62911,28730 Jun 15368,54422,97928,53011,142양질의 수익: NSHK.F는 고품질 수익을 보유하고 있습니다.이익 마진 증가: NSHK.F의 현재 순 이익률 (4.2%)은 지난해 (4.2%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NSHK.F는 지난 5년 동안 흑자전환하며 연평균 16.1%의 수익 성장을 기록했습니다.성장 가속화: NSHK.F은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: NSHK.F은 지난 1년 동안 수익이 감소(-3.6%)하여 Chemicals 업계 평균(-1.4%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: NSHK.F의 자본 수익률(4.3%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 13:52종가2026/03/02 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nippon Shokubai Co., Ltd.는 12명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullAstris Advisory Japan, K.K.Mikiya YamadaBarclaysTakashi EnomotoBofA Global Research9명의 분석가 더 보기
공시 • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026
공시 • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026
공시 • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026
공시 • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025
공시 • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025
공시 • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025
공시 • May 14Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2026.
공시 • Mar 27+ 1 more updateNippon Shokubai Co., Ltd. to Report Q1, 2027 Results on Aug 07, 2026Nippon Shokubai Co., Ltd. announced that they will report Q1, 2027 results at 1:00 PM, Tokyo Standard Time on Aug 07, 2026
공시 • Feb 28Nippon Shokubai Co., Ltd. to Report Fiscal Year 2026 Results on May 13, 2026Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2026 results at 1:00 PM, Tokyo Standard Time on May 13, 2026
공시 • Nov 18Nippon Shokubai Co., Ltd. to Report Q3, 2026 Results on Feb 05, 2026Nippon Shokubai Co., Ltd. announced that they will report Q3, 2026 results at 1:00 PM, Tokyo Standard Time on Feb 05, 2026
공시 • Aug 14Nippon Shokubai Co., Ltd. to Report Q2, 2026 Results on Nov 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q2, 2026 results on Nov 07, 2025
공시 • Jul 31Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 5,000,000 shares, representing 3.3% for ¥7,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 5,000,000 shares, representing 3.3% of its issued share capital (excluding treasury stock), for a total purchase price of ¥7,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 27, 2026. As of June 30, 2025, the company has 151,691,868 issued shares (excluding treasury stock) and 4,308,132 treasury shares.
공시 • Jun 26Nippon Shokubai's U.S. Group Company Acquires Iscc Plus Certification for Acrylic Acid and Superabsorbent PolymersNippon Shokubai Group companies in the United States have acquired ISCC PLUS certification for acrylic acid (hereinafter "AA") and superabsorbent polymers (hereinafter "SAP") produced locally. This enables Nippon Shokubai group to globally supply AA and SAP with a carbon footprint considered net zero. Through promoting the use of ISCC PLUS-certified AA and SAP, NipponShokubai Group aims to contribute to reducing environmental impact across the supply chain and to advancing a circular economy. Toward carbon neutrality by 2050, Nippon ShokubAI Group will continue to implement the "transformation" outlined in its long-term vision and mid-term management plan to enhance customer value. Nippon Shokubia Group commits and declares its compliance with the ISCC PLUS requirements in accordance with the latest ISCC regulations. ISCC (International Sustainability and Carbon Certification): It is a third-party certification program developed by International Sustainability and Carbon Certification (ISCC) system GmbH based in Germany to manage and guarantee sustainable raw materials and products such as biomass and recycled materials in the supply chain. Carbon footprint considered net zero: ISCC PLUS-certified products incorporate the biogenic CO2 removal associated with biomass growth into their carbon footprint calculations. The carbon footprints of these products are considered effectively net zero through the proportionally offset based on the share of biomass-derived feedstock allocated using the mass balance method. The mass balance method: When biomass-derived and petroleum-derived raw materials are used together in production, the proportion of biomass input can be allocated to specific end products. This method is officially recognized under the ISCC PLUS certification system.
공시 • Jun 24Nippon Shokubai Plans to Expand Its Gmp-Compliant Nucleic Acid Drug API Manufacturing Capacity TenfoldNippon Shokubai CO., LTD. has announced a plan to expand its GMP (1)-compliant manufacturing capacity for nucleic acid drug "active pharmaceutical ingredients" (APIs) tenfold in response to rapidly growing global demand in the nucleic acid drug market. Nucleic acid drugs are generally defined as "chemically synthesized drugs with oligonucleotides as active ingredients that exert their effects without being translated into proteins." As a new modality following small molecule and antibody drugs, they are expected to be applied in areas such as rare diseases, neurological disorders, and cancers -- fields where conventional treatments have been limited. The capacity expansion will involve the installation of a large-scale production line with ten times the capacity (several kilograms per batch) of the company's existing line. The new facility is scheduled to begin operation in 2027, making it one of Japan's largest CDMOs, capable of manufacturing nucleic acid drug APIs for common diseases that require large-scale supply. The company will strengthen its manufacturing system to meet a wide range of needs, from non-clinical stages to large-scale commercial production. Leveraging Nippon Shokubai's long-standing expertise in organic synthesis and rigorous quality control systems, the company manufactures oligonucleotides and peptides, which are medium-sized molecule APIs. Its GMP-compliant facilities, among the most advanced in Japan, have been audited and visited by multiple pharmaceutical companies, all of which have given high evaluations, establishing Nippon ShokubAI's strong reputation in the industry. The company will continue to provide flexible contract manufacturing services that meet diverse needs and contribute to a sustainable society by ensuring a stable supply of medium-sized molecule APIs that support human health and life.
공시 • May 31Nippon Shokubai Co., Ltd. to Report Q1, 2026 Results on Aug 07, 2025Nippon Shokubai Co., Ltd. announced that they will report Q1, 2026 results on Aug 07, 2025
공시 • May 13+ 3 more updatesNippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 19, 2025.
공시 • Apr 02Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation.Nippon Shokubai Co., Ltd. (TSE:4114) agreed to acquire Emulsion Technology Co.,Ltd. from JSR Corporation for ¥7.2 billion on November 12, 2024. As part of consideration, ¥7.2 billion is paid towards common equity of Emulsion Technology Co.,Ltd. For the period ending March 31, 2024, Emulsion Technology Co.,Ltd. reported total revenue of ¥13.3 billion, EBIT of ¥918 million and net income of ¥647 million. The expected completion of the transaction is April 1, 2025. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Emulsion Technology Co.,Ltd. from JSR Corporation on April 1, 2025.
공시 • Feb 06Nippon Shokubai Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 13, 2025
공시 • Dec 12Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd.Nippon Shokubai Co., Ltd. (TSE:4114) acquired Lilac Pharma Co., Ltd. on December 9, 2024. Nippon Shokubai Co., Ltd. (TSE:4114) completed the acquisition of Lilac Pharma Co., Ltd. on December 9, 2024.
공시 • Nov 11Nippon Shokubai Co., Ltd. to Report Q3, 2025 Results on Feb 06, 2025Nippon Shokubai Co., Ltd. announced that they will report Q3, 2025 results at 3:00 PM, Tokyo Standard Time on Feb 06, 2025
공시 • Aug 15Nippon Shokubai Co., Ltd. to Report Q2, 2025 Results on Nov 07, 2024Nippon Shokubai Co., Ltd. announced that they will report Q2, 2025 results on Nov 07, 2024
공시 • May 15Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024Nippon Shokubai Co., Ltd., Annual General Meeting, Jun 20, 2024.
공시 • May 14Nippon Shokubai Co., Ltd. (TSE:4114) announces an Equity Buyback for 4,000,000 shares, representing 2.59% for ¥5,000 million.Nippon Shokubai Co., Ltd. (TSE:4114) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.59% of its issued share capital (excluding treasury stock), for a total purchase price of ¥5,000 million. The purpose of the program is to improve the shareholder return as well as capital efficiency and to implement flexible capital policy in response to change in the business environment. The program will be valid till February 28, 2025. As of March 31, 2024, the company has 154,642,750 issued shares (excluding treasury stock) and 1,357,240 treasury shares.
공시 • Mar 02Nippon Shokubai Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024Nippon Shokubai Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
공시 • Feb 09+ 1 more updateNippon Shokubai Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2023Nippon Shokubai Co., Ltd. announced that For the fiscal year ending March 31, 2023, the company to forecasts to pay a dividend of JPY 90.00 per share as compared to JPY 90.00 per share paid a year ago.